What else can you tell me?

The study has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) and by the Cambridge East Research Ethics Committee (Health Research Authority, ref 20/EE/0101). COVID-19 comparisons were funded by UK Research and Innovation and the National Institute for Health and Care Research, not the makers of any of the study treatments (who may provide the treatment free of charge to the trial). The "flu" comparisons are funded by FluLab, an organisation founded to advance innovative approaches for the prevention and treatment of influenza.

If we find out any new information that might affect your decision to stay in the study, we will give it to you. The University of Oxford, as sponsor, has appropriate insurance in place in the unlikely event that you suffer any harm as a direct consequence of your participation in this study. NHS indemnity operates in respect of the clinical treatment that is provided.